Skip to main content
Clinical Trials/NCT07519798
NCT07519798
Enrolling By Invitation
Not Applicable

The Effects of Transcranial Temporal Interferential Electrical Stimulation on Cognitive Function, Dual-Task Performance and Neuroplasticity in Individuals With Mild Cognitive Impairment

Shanghai University of Sport1 site in 1 country40 target enrollmentStarted: April 15, 2026Last updated:

Overview

Phase
Not Applicable
Status
Enrolling By Invitation
Sponsor
Shanghai University of Sport
Enrollment
40
Locations
1
Primary Endpoint
Change in Montreal Cognitive Assessment (MoCA) Score

Overview

Brief Summary

To explore the effects of transcranial temporal interference stimulation (tTIS) on cognitive function and dual-task walking performance, as well as its underlying neuroimaging mechanisms, in individuals with mild cognitive impairment.

Detailed Description

This is a randomized, double-blind, sham-controlled, crossover trial. Participants aged 60-80 years with mild cognitive impairment (MoCA < 26, CDR = 0.5) will receive a single 20-minute session of individualized 5 Hz transcranial temporal interference stimulation (tTIS) targeting the left hippocampus (2 mA, 2000/2005 Hz carriers) and a sham session in random order, with a 7-day washout period. The primary outcomes are change in MoCA score, dual-task gait/balance cost, and working memory performance. Secondary outcomes include change in brain function and brain structure. The study aims to enroll 40 participants. Safety and tolerability will be assessed via structured questionnaires.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
60 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 60-80 years
  • Community-dwelling
  • Montreal Cognitive Assessment (MoCA) score \< 26
  • Clinical Dementia Rating (CDR) score = 0.5
  • Activities of Daily Living (ADL) score \< 26 (largely intact daily function)
  • Does not meet criteria for dementia diagnosis (based on DSM-5 or NIA-AA criteria)
  • No contraindications for MRI examination (no metallic implants, no claustrophobia)
  • Able to provide written informed consent

Exclusion Criteria

  • Neurological conditions that may cause cognitive decline (e.g., cerebrovascular disease, encephalitis, Parkinson's disease, Huntington's disease)
  • Severe visual, auditory, or language impairments preventing completion of neuropsychological assessments
  • Severe depression (Geriatric Depression Scale \> 10) or other major psychiatric disorders
  • History of seizures or epilepsy
  • Previous deep brain stimulation or electroconvulsive therapy within 6 months
  • Alcohol or substance dependence
  • Concurrent participation in another interventional clinical trial
  • Contraindications for non-invasive brain stimulation: electronic or ferromagnetic implants, non-MRI compatible metal implants, history of seizures, pregnancy

Arms & Interventions

Active TIS followed by Placebo TIS

Experimental

Participants first receive single-session active TIS targeting the hippocampus for approx. 20 minutes. Following a washout period, they receive placebo (sham) TIS.

Intervention: Active Temporal Interference Stimulation (TIS) (Device)

Active TIS followed by Placebo TIS

Experimental

Participants first receive single-session active TIS targeting the hippocampus for approx. 20 minutes. Following a washout period, they receive placebo (sham) TIS.

Intervention: Placebo / Sham TIS (Device)

Placebo TIS followed by Active TIS

Experimental

Participants first receive single-session placebo (sham) TIS for approx. 20 minutes. Following a washout period, they receive active TIS targeting the hippocampus.

Intervention: Active Temporal Interference Stimulation (TIS) (Device)

Placebo TIS followed by Active TIS

Experimental

Participants first receive single-session placebo (sham) TIS for approx. 20 minutes. Following a washout period, they receive active TIS targeting the hippocampus.

Intervention: Placebo / Sham TIS (Device)

Outcomes

Primary Outcomes

Change in Montreal Cognitive Assessment (MoCA) Score

Time Frame: Baseline and immediately after intervention

Change in Gait-Related and Balance-Related Dual-Task Cost

Time Frame: Baseline and immediately after intervention

Change in Working Memory Performance

Time Frame: Baseline and immediately after intervention

Secondary Outcomes

  • Change in Brain function(Baseline and immediately after intervention)
  • Chang in Brain structure(Baseline and immediately after intervention)

Investigators

Sponsor
Shanghai University of Sport
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Weijie Fu, Ph.D.

Professor

Shanghai University of Sport

Study Sites (1)

Loading locations...

Similar Trials